GlucoTrack Advances LT-100 to Single-Injection Development Strategy

GlucoTrack ( (GCTK) ) just unveiled an announcement.
Pharmabiz

Lokahi Therapeutics advances LT-100 development strategy toward single-injection administration

Lokahi Therapeutics advances LT-100 development strategy toward single-injection administration: Rutherford, New Jersey Friday, July 31, 2026, 17:00 Hrs [IST] Lokahi Therapeutics ...

Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration

RUTHERFORD, N.J. & LA JOLLA, Calif.-- (BUSINESS WIRE)--Jul 29, 2026-- ...
Frontiers

Early immune responses to intradermal lipopolysaccharide in healthy volunteers: prednisolone’s impact on TLR4-mediated inflammation

Intradermal lipopolysaccharide (LPS) administration is a well-established model to investigate Toll-like receptor 4 (TLR4)-mediated inflammation in human skin. Previous studies have shown strong ...
Time

The 10 Most Influential Health and Life Science Companies of 2026

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Business Wire

Gilead to Present New HIV Treatment and Prevention Data at CROI 2026, With a Focus on Expanding Options

– Pivotal Phase 3 Findings Support the Potential of a Novel Single-Tablet Combination of Bictegravir and Lenacapavir for HIV Treatment – – Latest Data from the PURPOSE Program Further Demonstrates the ...
C&EN

Intradermal Injection of a Thermoresponsive Polymeric Dexamethasone Prodrug (ProGel-Dex) Ameliorate Dermatitis in an Imiquimod (IMQ)-Induced Psoriasis-like Mouse Model

Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States ...
BMJ

Perineural injections of incobotulinumtoxin-A for diabetic neuropathic pain of the lower extremities: protocol for a phase II, single-centre, double-blind, randomised, placebo ...

Introduction Diabetic neuropathic pain (DNP) is a debilitating complication affecting 15–20% of people with diabetes and is a predictor of depression, poor sleep and decreased quality of life. Current ...